Hart wonders if retatrutide could take the top spot after an FDA approval, and notes it may raise heart rate and sometimes cause skin sensitivity.
Recap by typeshit. Post by @drmikehart on Instagram.
Popular Mechanics traces how her 1980s work at Mass General showed GLP-1 triggers insulin release. Gallup now puts GLP-1 weight loss use at about 11% of Americans.
Barzilai highlights trial results on retatrutide in adults with sleep apnea and obesity or overweight, a new use being tested for Lilly's drug.
The Washington meeting runs November 14 to 17, with primary REDEFINE 9 results and pediatric semaglutide research for kids 6 to under 12.
Researchers tracked spending on drinks while out and found a sharp drop among people taking GLP-1 medications.
AllSci looks at how Eli Lilly's third quarter shaped up, with retatrutide adding weight to its GLP-1 lineup and more cancer drugs moving through development.
West Pharmaceutical shares are up about 20% since CNBC flagged the valuation in August, and the latest earnings give it reasons to expect further gains.
Loading…